Recent Patents on Inflammation & Allergy Drug Discovery,volume 9,issue 2  (08-2015)

Period of time： 2015年2期

Publisher： Bentham Science Publishers

Founded in： 2007

Total resources： 29

E-ISSN： 2212-2710|9|2

ISSN： 1872-213X

Subject： T-1 Technology Status and Development

Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Recent Patents on Inflammation & Allergy Drug Discovery,volume 9,issue 2

Menu

Meet Our Editorial Board Member:

Recent Patents on Inflammation & Allergy Drug Discovery,volume 9,issue 2 , Vol. 9, Iss. 2, 2015-08 , pp. 85-85

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Patents and Recent Innovations in Topical Membrane Therapy of Refractory Rhinosinusitis

Recent Patents on Inflammation & Allergy Drug Discovery,volume 9,issue 2 , Vol. 9, Iss. 2, 2015-08 , pp. 86-101

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Alcohol Abuse and Pancreatic Diseases: An Overview

Recent Patents on Inflammation & Allergy Drug Discovery,volume 9,issue 2 , Vol. 9, Iss. 2, 2015-08 , pp. 102-106

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Recent Patents of Complementary and Alternative Medicine for Allergic Rhinitis

Recent Patents on Inflammation & Allergy Drug Discovery,volume 9,issue 2 , Vol. 9, Iss. 2, 2015-08 , pp. 107-119

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Formulation of Nanoparticles Against TB - A Review

Recent Patents on Inflammation & Allergy Drug Discovery,volume 9,issue 2 , Vol. 9, Iss. 2, 2015-08 , pp. 120-127

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Impacts of Particulate Air Pollution on Asthma: Current Understanding and Future Perspectives

Recent Patents on Inflammation & Allergy Drug Discovery,volume 9,issue 2 , Vol. 9, Iss. 2, 2015-08 , pp. 128-135

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Bevacizumab for Malignant Brain Gliomas. Which is the Current Evidence?

Recent Patents on Inflammation & Allergy Drug Discovery,volume 9,issue 2 , Vol. 9, Iss. 2, 2015-08 , pp. 136-143

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Pharmacokinetics and Systemic Activity of a New Patent of an Inhaled Corticosteroid/Long-Acting bgr;2-Agonist Combination for Use in Asthma Therapy: Fluticasone Furoate/Vilanterol Trifenatate

Recent Patents on Inflammation & Allergy Drug Discovery,volume 9,issue 2 , Vol. 9, Iss. 2, 2015-08 , pp. 144-150

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Neuropsychological Effects of Mercury Exposure Among Dentists in Monastir City

Recent Patents on Inflammation & Allergy Drug Discovery,volume 9,issue 2 , Vol. 9, Iss. 2, 2015-08 , pp. 151-158

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Patent Selections:

Recent Patents on Inflammation & Allergy Drug Discovery,volume 9,issue 2 , Vol. 9, Iss. 2, 2015-08 , pp. 159-164

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Previous 1 2 Next Display item(s) per page Total 12 item(s)